General Information of Drug Off-Target (DOT) (ID: OTK7R6HC)

DOT Name Lens fiber membrane intrinsic protein (LIM2)
Synonyms MP18; MP19; MP20
Gene Name LIM2
Related Disease
Cataract 19 multiple types ( )
Lymphatic malformation 1 ( )
Cataract 20 multiple types ( )
Glioma ( )
Cataract ( )
Total early-onset cataract ( )
Adult respiratory distress syndrome ( )
Microphthalmia ( )
Reducing body myopathy ( )
UniProt ID
LMIP_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00822
Sequence
MYSFMGGGLFCAWVGTILLVVAMATDHWMQYRLSGSFAHQGLWRYCLGNKCYLQTDSIAY
WNATRAFMILSALCAISGIIMGIMAFAHQPTFSRISRPFSAGIMFFSSTLFVVLALAIYT
GVTVSFLGRRFGDWRFSWSYILGWVAVLMTFFAGIFYMCAYRVHECRRLSTPR
Function
Present in the thicker 16-17 nm junctions of mammalian lens fiber cells, where it may contribute to cell junctional organization. Acts as a receptor for calmodulin. May play an important role in both lens development and cataractogenesis.
Tissue Specificity Eye lens specific.

Molecular Interaction Atlas (MIA) of This DOT

9 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cataract 19 multiple types DISHHVZB Definitive Autosomal recessive [1]
Lymphatic malformation 1 DIS857QZ Definitive Biomarker [2]
Cataract 20 multiple types DISN0IHS Strong Biomarker [3]
Glioma DIS5RPEH Strong Biomarker [4]
Cataract DISUD7SL moderate Biomarker [1]
Total early-onset cataract DISACMEZ Supportive Autosomal dominant [1]
Adult respiratory distress syndrome DISIJV47 Limited Biomarker [5]
Microphthalmia DISGEBES Limited Biomarker [6]
Reducing body myopathy DISFDWS0 Limited Genetic Variation [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Lens fiber membrane intrinsic protein (LIM2). [8]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Lens fiber membrane intrinsic protein (LIM2). [11]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Quercetin DM3NC4M Approved Quercetin increases the expression of Lens fiber membrane intrinsic protein (LIM2). [9]
SNDX-275 DMH7W9X Phase 3 SNDX-275 decreases the expression of Lens fiber membrane intrinsic protein (LIM2). [10]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of Lens fiber membrane intrinsic protein (LIM2). [12]
------------------------------------------------------------------------------------

References

1 A missense mutation in LIM2 causes autosomal recessive congenital cataract. Mol Vis. 2008 Jun 23;14:1204-8.
2 Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.Blood. 1999 Feb 1;93(3):1032-7.
3 A missense mutation in the LIM2 gene is associated with autosomal recessive presenile cataract in an inbred Iraqi Jewish family.Am J Hum Genet. 2002 May;70(5):1363-7. doi: 10.1086/340318. Epub 2002 Mar 26.
4 CD133 in brain tumor: the prognostic factor.Oncotarget. 2017 Feb 14;8(7):11144-11159. doi: 10.18632/oncotarget.14406.
5 MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome.BMC Med Genomics. 2014 Jul 28;7:46. doi: 10.1186/1755-8794-7-46.
6 Localization of lens intrinsic membrane protein MP19 and mutant protein MP19(To3) using fluorescent expression vectors.Mol Vis. 2002 Oct 11;8:372-88.
7 Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.Neuropediatrics. 2010 Feb;41(1):43-6. doi: 10.1055/s-0030-1254101. Epub 2010 Jun 22.
8 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
9 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
10 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
12 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.